Cargando…
Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies
PURPOSE: Since the 1980s, both the incidence of differentiated thyroid cancer (DTC) and use of radioactive iodine (RAI) treatment increased markedly. RAI has been associated with an increased risk of leukemia, but risks of second solid malignancies remain unclear. We aimed to quantify risks of secon...
Autores principales: | Pasqual, Elisa, Schonfeld, Sara, Morton, Lindsay M., Villoing, Daphnée, Lee, Choonsik, Berrington de Gonzalez, Amy, Kitahara, Cari M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061144/ https://www.ncbi.nlm.nih.gov/pubmed/35044839 http://dx.doi.org/10.1200/JCO.21.01841 |
Ejemplares similares
-
Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism
por: Kitahara, Cari M., et al.
Publicado: (2019) -
Association of Radioactive Iodine, Antithyroid Drug, and Surgical Treatments With Solid Cancer Mortality in Patients With Hyperthyroidism
por: Kitahara, Cari M., et al.
Publicado: (2020) -
Is radioactive iodine-
(
131
)
treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?
por: de Souza, Marcelo Cruzick, et al.
Publicado: (2015) -
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence
por: Reinecke, Maximilian J., et al.
Publicado: (2022) -
Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: A Systematic Review and Meta-analysis
por: Shim, Sung Ryul, et al.
Publicado: (2021)